Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport

Journal of Hepatology

Volumn 24, Issue 3, 1996, Pages 343-352

  Beukeveld, Gerard J J ^a   Veld, Gerda In't ^a   Havinga, Rick ^a   Groen, Albert K ^b   Wolthers, Bert G ^a   Kuipers, Folkert ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

canalicular multispecific organic anion transporter; coproporphyrin I; coproporphyrin III; erythropoietic protoporphyria; gel permeation chromatography; Groningen Yellow rat; lipid vesicles; Mdr2 P glycoprotein; micelles

Indexed keywords

COPROPORPHYRIN; LIPID; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANION TRANSPORT; ARTICLE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; LIPID SECRETION; MALE; MICELLE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0343290385     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80015-8     Document Type: Article

References (60)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGrawHill, 1989: 1305-65.
2. Elder GH, Smith SG, Smyth SJ. Laboratory investigation of porphyrias. Ann Clin Biochem 1990; 27: 395-410.
3. Avner DL, Berenson MM. Hepatic clearance and biliary secretion of protoporphyrin in isolated, in situ-perfused rat liver. J Lab Clin Med 1982; 99: 885-94.
4. Lefkowitch JH, Feng-Chen KC, Sklar JA, Poh-Fitzpatrick MB. Cholic acid amelioration of light and electron microscopic hepatic lesions in experimental protoporphyria. Hepatology 1983; 3: 399-406.
5. Avner DL, Berenson MM. Effect of choleretics on canalicular transport of protoporphyrin in the rat liver. Am J Physiol 1982; 242: G347-53.
6. Berenson MM, Garcia-Marin JJ, Gunther C. Effect of bile acid hydroxylation on biliary protoporphyrin excretion in rat liver. Am J Physiol 1988; 255: G382-8.
7. Berenson MM, Garcia-Marin JJ, Larsen R, Avner D. Effect of bile acids on hepatic protoporphyrin metabolism in perfused rat liver. Gastroenterology 1987; 93: 1086-93.
8. Berenson MM, Von Welch, Garcia-Marin JJ. Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy. J Lab Clin Med 1991; 118: 89-98.
9. Poh-Fitzpatrick, Sklar JA, Goldsman C, Lefkowitch JH. Protoporphyrin hepatopathy: effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria. J Clin Invest 1983; 72: 1449-58.
10. Perez-Barriocanal F, Redondo-Torres JG, Villanueva GR, Arteche E, Berenson MM, Marin JGG. Protoporphyrin-IX induced impairment of biliary lipid secretion in the rat. Clin Sci 1989; 77: 473-8.
11. Berenson MM, El-Mir MY. Mechanism of action of bile acids on biliary protoporphyrin excretion. Hepatology 1992; 16: 119A.
12. Frank M, Doss MO. Severe liver disease in protoporphyria. Curr Probl Dermatol 1991; 20: 123-35.
13. Wagner S, Doss MO, Wittekind C, Bäcker U, Meessen D, Schmidt FW. Erythrohepatische Protoporphyrie mit rasch progredienter Leberzirrhose. Dtsch Med Wochenschr 1989; 114: 1837-41.
14. Doss MO, Frank M. Hepatobiliary implications and complications in protoporphyria, a 20-year study. Clin Biochem 1989; 22: 223-9.
15. Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, Ascher NL. Liver transplantation in a patient with protoporphyria. Gastroenterology 1989; 97: 188-94.
16. Poison RJ, Lim CK, Rolles K, Calne RY, Williams R. The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation 1988; 46: 386-9.
17. Mion FBC, Faure JL, Berger F, McGregor B, Perrot H, Paliard P. Liver transplantation for erythropoietic protoporphyria. J Hepatol 1992; 16: 203-7.
18. Shehade SA, Chalmers RJG, Prescott RJ. Predictable and unpredictable hazards of erythropoietic protoporphyria. Clin Exp Derm 1991; 16: 185-7.
19. Steinmüller T, Doss MO, Steffen R, Blumhardt G, Bechstein WO, Frank M, Sieg I, Kretsschmar R, Neuhaus P. Lebertransplantion bei erythrohepatischer Protoporphyrie. Dtsch Med Wochenschr 1992; 117: 1097-102.
20. Meerman L, Karrenbeld A, Hattum van J, Gouw AS, Kleibeuker JH, Slooff MJH, Haagsma EB. Recurrence of ultrastructural liver cell damage after liver transplantation for erythropoietic protoporphyria. Neth J Med 1993; 43: A9.
21. Gordeuk VR, Brittenham GM, Hawkins CW, Mukhtar H, Bickers DR. Iron therapy for hepatic dysfunction in erythropoietic protoporphyria. Ann Intern Med 1986; 105: 27-31.
22. Spiva DA, Lewis CE. Erythropoietic protoporphyria: therapeutic response to combined erythrocyte exchange and plasmapheresis. Photodermatol 1984; 1: 211-20.
23. Bechtel MA, Bertolone SJ, Hodge SJ. Transfusion therapy in a patient with erythropoietic protoporphyria. Arch Dermatol 1981; 117: 99-101.
24. Dobozy A, Csató M, Siklósi C, Simon N. Transfusion therapy for erythropoietic protoporphyria. Br J Dermatol 1983; 109: 571-6.
25. Wijk van HJ, Hattum van J, Baart de la Faille H, Berg van den JWO, Edinxhoven-Bosdijk A, Wilson JHP. Blood exchange and transfusion therapy for acute cholestasis in protoporphyria. Dig Dis Sci 1988; 33: 1621-5.
26. Todd DJ, Callender ME, Mayne EE, Walsh M, Burrows D. Erythropoietic protoporphyria, transfusion therapy and liver disease. Br J Dermatol 1992; 127: 534-7.
27. Rank JM, Straka JG, Bloomer JR. Liver in disorders of porphyrin metabolism (review article). J Gastroenterol Hepatol 1990; 5: 573-85.
28. Rademakers LHPM, Cleton MI, Kooijman C, Baart de la Faille H, Hattum van J. Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment. Hepatology 1990; 11: 449-57.
29. McCullough AJ, Barron D, Mullen KD, Petrelli M, Chung Park M, Mukhtar H, Bickers DR. Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. Gastroenterology 1988; 94: 177-81.
30. Van Hattum J, Baart de la Faille H, van der Berg JWO, Edixhoven-Bosdijk A, Wilson JHP. Chenodeoxycholic acid therapy in erythropoietic protoporphyria. J Hepatol 1986; 3: 407-12.
31. Tazuma S, Holzbach RT. Transport of conjugated bilirubin and other organic anions in bile: relation to biliary lipid structures. Proc Natl Acad Sci USA 1987; 84: 2052-6.
32. Tazuma S, Barnhart RL, Reeve LE, Tokumo H, Holzbach RT. Biliary secretion of organic anions in the dog: association with defined lipid particles. Am J Physiol 1988; 255: G745-51.
33. Kuipers F, Radominska A, Zimniak P, Little JM, Havinga R, Vonk RJ, Lester R. Defective secretion of bile acid-3-O-glucuronides in rats with hereditary conjugated hyperbilirubinemia. J Lipid Res 1989; 30: 1835-45.
34. Kuipers F, Heslinga H, Havinga R, Vonk RJ. Intestinal absorption of lithocholic acid sulfates in the rat: inhibitory effects of calcium. Am J Physiol 1986; 251: G189-94.
35. Kuipers F, Enserink M, Havinga R, van der Steen ABM, Hardonk MJ, Fevery J, Vonk RJ. Separate transport system for biliary secretion of sulfated and unsulfated bile acids in the rat. J Clin Invest 1988; 81: 1593-9.
36. Kuipers F, Havinga R, Bosschieter H, Toorop GP, Hindriks FR, Vonk RJ. Enterohepatic circulation in the rat. Gastroenterology 1985; 88: 403-11.
37. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, Ottenhof R, Van der Lugt NMT, Van Roon MA, Van der Valk MA, Offerhaus GJA, Berns AJM, Borst P. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-62.
38. Oude Elferink RPJ, Ottenhof R, Van Wijland M, Smit JJM, Schinkel AH, Groen AK. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J Clin Invest 1995; 95: 31-8.
39. Verkade HJ, Wolbers MJ, Havinga R, Uges DRA, Vonk RJ, Kuipers F. The uncoupling of biliary lipid from bile acid secretion by organic anions in the rat. Gastroenterology 1990; 99: 1485-92.
40. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Biophys 1959; 37: 911-7.
41. Gamble W, Vaughan M, Kruth MS, Avigan J. Procedure for determination of free and total cholesterol in micro- and nanogram amounts suitable for studies with cultured cells. J Lipid Res 1978; 19: 1068-71.
42. Böttcher CFJ, Van Gent CM, Pries C. A rapid and sensitive sub-micro-phosphorus determination. Anal Chim Acta 1961; 24: 203-4.
43. Beukeveld GJJ, Meerman L, Huizenga JR, Venekamp-Hoolsema EEA, Gips CH, Wolthers BG. Determination of porphyrins in bile using high performance liquid chromatography and some clinical applications. Eur J Clin Chem Clin Biochem 1994; 32: 153-9.
44. Beukeveld GJJ, Nagel GT, Ruyter-Buitenhuis de AW, Kwarts EW, Wolthers BG. Determination of porphyrins in blood, urine and faeces by means of HPLC and its application in establishing porphyrias. Biochim Clin 1987; 11: 203-13.
45. Kuipers F, Derksen JTP, Gerding A, Scherphof GL, Vonk RJ. Biliary lipid secretion in the rat. The uncoupling of biliary cholesterol and phospholipid secretion from bile acid secretion by sulfated glycolithocholic acid. Biochem Biophys Acta 1987; 922: 136-44.
46. Azis MA, Watson CJ. An analysis of the porphyrins of normal and cirrhotic human liver and normal bile. Clin Chim Acta 1969; 26: 525-31.
47. Sömjen GJ, Gilat T. Contribution of vesicular and micellar carriers to cholesterol transport in human bile. J Lipid Res 1985; 26: 699-704.
48. Cohen DE, Kaler EW, Carey MC. Cholesterol carriers in human bile: are "lamellae" involved? Hepatology 1993; 18: 1522-32.
49. Cohen DE, Angelico M, Carey MC. Quasielastic light scattering evidence for vesicular secretion of biliary lipids. Am J Physiol 1989; 257: G1-G8.
50. Ulloa N, Garrido J, Nervi F. Ultracentrifugal isolation of vesicular carriers of biliary cholesterol in native human and rat bile. Hepatology 1987; 7: 235-44.
51. Verkade HJ, Vonk RJ, Kuipers F. Mechanism of bile acid. Induced biliary secretion. Hepatology 1995; in press.
52. Oude Elferink RPJ, Ottenhof R, Radominska A, Hofmann AF, Kuipers F, Jansen PLM. Inhibition of glutathione-conjugate secretion from isolated hepatocytes by dipolar bile acids and other organic anions. Biochem J 1991; 274: 281-6.
53. Kitamura T, Jansen P, Hardenbrook C, Kamimoto Y, Gatmaitan Z, Arias IM. Defective ATP-dependent bile canalicular transport of organic anions in mutant (TR-) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci USA 1990; 87: 3557-61.
54. Jansen PLM, Peters WH, Lamers WH. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 1985; 5: 573-9.
55. Ruetz S, Gros P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 1994; 77: 1071-82.
56. Smith AJ, Timmermans-Hereijgers JLPM, Roelofsen B, Witrz KWA, van Blitterwijk WJ, Smit JJM, Schinkel AH, Borst P. The human MDR3 P-glycoprotein promotes translocation of phosphotidylcholine through the plasma membrane of fibroblast from transgenic mice. FEBS Lett 1994; 354: 263-6.
57. Vonk RJ, van de Veen H, Prop G, Meijer DKF. The influence of taurocholate and dehydrocholate choleresis on plasma disappearance and biliary excretion of indocyanine green in the rat. Naunyn Schmiedeberg's Arch Pharmacol 1974; 282: 401-10.
58. Berenson MM, Zhang LK, Wang X. Uncoupling biliary bile acid (BA) and phospholipid (PL) reduces protoporphyrin (PP) and indocyanine green (ICG) but not phenol red (PR) excretion: evidence that hydrophobic organic anion excretion is linked to phospholipid. Hepatology 1994; 20: 331A.
59. Galán AI, Román ID, Munoz ME, Cava F, Gonzalez-Buitrago JM, Esteller A, Jimenez R. Inhibition of biliary lipid and protein secretion by cyclosporine A in the rat. Biochem Pharmacol 1992; 44: 1105-13.
60. Moore MR. International review of drugs in acute porphyria. Int J Biochem 1980; 12: 1089-97